You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

fluzoparib

Showing 26 - 32 of 32
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Treatment in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA Mutation Trial in Shanghai (Fluzoparib;

Recruiting
  • Treatment in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA Mutation
  • Fluzoparib; Apatinib
  • +2 more
  • Shanghai, China
    Jiangsu HengRui Medicine Co., Ltd.
Aug 6, 2020

Small Cell Lung Cancer Trial in Chengdu (Fluzoparib, temozolomide, SHR-1316)

Unknown status
  • Small Cell Lung Cancer
  • Fluzoparib
  • +2 more
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Jun 19, 2020

Metastatic Pancreatic Cancer Trial in China (Fluzoparib, Placebo)

Unknown status
  • Metastatic Pancreatic Cancer
  • Fluzoparib
  • Placebo
  • Hefei, Anhui, China
  • +23 more
Jan 7, 2021

Healthy Male Subjects Trial in Hangzhou (Fluzoparib, Rifampicin)

Completed
  • Healthy Male Subjects
  • Hangzhou, Zhejiang, China
    First Affiliated Hospital of Zhejiang University School of Medic
Feb 25, 2020

Advanced Cancer Trial in Hunan (Fluzoparib, Fluconazole)

Completed
  • Advanced Cancer
  • Hunan, Hunan, China
    Early Cancer Research Center of Hunan Cancer Hospital
Dec 8, 2019

Recurrent and Metastatic Gastric Cancer Trial in Beijing (Fluzoparib, Apatinib, Paclitaxel)

Unknown status
  • Recurrent and Metastatic Gastric Cancer
  • Fluzoparib
  • +2 more
  • Beijing, Beijing, China
    The Affiliated Hospital of Military Medical Sciences
Mar 5, 2017

Solid Tumor Trial in Changchun (Fluzoparib)

Completed
  • Solid Tumor
  • Fluzoparib
  • Changchun, Jilin, China
    the First Hosital of Jilin University
Feb 20, 2017